Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Monk, Bradley J Tewari, Krishnansu S Dubot, Coraline Caceres, M Valeria Hasegawa, Kosei Shapira-Frommer, Ronnie Salman, Pamela Yañez, Eduardo Gümüş, Mahmut Hurtado de Mendoza, Mivael Olivera Samouëlian, Vanessa Castonguay, Vincent Arkhipov, Alexander Tekin, Cumhur Li, Kan Martin Nguyen, Allison Monberg, Matthew J Colombo, Nicoletta Lorusso, Domenica